The relationship between risperidone plasma levels and dopamine D2 occupancy: a positron emission tomographic study.
Remington
G
G
Kapur
S
S
Zipursky
R
R
D014150:Antipsychotic Agents / Q000097:blood* / Q000627:therapeutic use; D002250:Carbon Radioisotopes; D018492:Dopamine Antagonists / Q000097:blood* / Q000627:therapeutic use; D006801:Humans; D020891:Raclopride; D017448:Receptors, Dopamine D2 / Q000378:metabolism*; D018967:Risperidone / Q000097:blood* / Q000627:therapeutic use; D012457:Salicylamides; D012559:Schizophrenia / Q000188:drug therapy / Q000378:metabolism*; D014055:Tomography, Emission-Computed
D014150:Antipsychotic Agents; D002250:Carbon Radioisotopes; D018492:Dopamine Antagonists; D017448:Receptors, Dopamine D2; D012457:Salicylamides; D020891:Raclopride; D018967:Risperidone